Disaster research planning pays off after hurricane
<img width="100" src="https://factor.niehs.nih.gov/sites/niehs-factor/files/styles/large/public/2019/10/feature/2-feature-hurricane/thumb877366.jpg?itok=SJibOnVF" /><br /><p>The first data from environmental health studies launched after&nbsp;Hurricane Harvey&nbsp;were shared at a Baylor College of Medicine symposium.</p> (read more) (Source: Environmental Factor - NIEHS Newsletter)
Source: Environmental Factor - NIEHS Newsletter - February 3, 2023 Category: Environmental Health Source Type: news

St. Luke ’s Health returns to Cigna network with new deal
The deal means over 66,000 patients with Cigna insurance can receive in-network services from St. Luke ’s Health hospitals or Baylor College of Medicine doctors. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - February 1, 2023 Category: Health Management Authors: Jishnu Nair Source Type: news

Baylor College of Medicine to anchor Texas Medical Center Helix Park building
Baylor College of Medicine is set to anchor one of Texas Medical Center's buildings in its upcoming life sciences campus, Helix Park (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - January 10, 2023 Category: Health Management Authors: Jishnu Nair Source Type: news

New Year, New Travel: Stay Healthy on the Move
SATURDAY, Jan. 7, 2023 -- Travel can be fun, but taxing. As the pandemic ebbs and people venture back out into the world, an expert from Baylor College of Medicine in Houston offers tips for ensuring a healthier, more peaceful vacation or work... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 7, 2023 Category: General Medicine Source Type: news

Baylor Study: Mesothelioma ‘Staged Surgical Approach’ Increases Survival
In this study, there were no immediate deaths following the first surgery, and all 14 patients proceeded to the second surgery. There were two patients – both starting with the EPP – who died within 90 days of the abdominal surgery. “When considering bicavitary cytoreductive surgery for mesothelioma, we would recommend only performing ePD and avoiding EPP in this cohort of patients,” authors concluded. Baylor Medical Center thoracic surgeon Dr. R. Taylor Ripley was the lead author of the study. One of the co-authors was surgical oncologist Dr. Paul Sugarbaker, brother of Dr. David Sugarbaker and a pioneer in ...
Source: Asbestos and Mesothelioma News - January 4, 2023 Category: Environmental Health Authors: Fran Mannino Tags: Clinical Trials/Research/Emerging Treatments Mesothelioma Source Type: news

Nobel-nominated vaccine expert warns of Covid complacency: ‘We’re still losing too many lives’
Dr Peter Hotez says Joe Biden was wrong to say pandemic is over and warns US risks another deadly coronavirus wave soonJoe Biden was wrong to declare the coronavirus pandemic over in the US, one of the country ’s leading experts on the virus has told the Guardian.Dr Peter Hotez, co-director of the Center for Vaccine Development at Texas Children ’s hospital and dean of the National School of Tropical Medicine at Baylor College of Medicine, said that the US president’sstatement in September, that “the pandemic is over”, was mistaken and a poor message to send to the American public.Continue reading... (Source: Gua...
Source: Guardian Unlimited Science - December 23, 2022 Category: Science Authors: Erum Salam Tags: Coronavirus Infectious diseases Science US news Health policy Source Type: news

Mesothelioma Surgery With Immunotherapy Proves Effective in Study
An immunotherapy combination given before aggressive surgery has shown impressive effectiveness in extending survival for pleural mesothelioma patients in a recent phase II clinical trial at Baylor College of Medicine. The combination of immune checkpoint inhibitors durvalumab and tremelimumab showed an ability to effectively alter the intratumoral immune system and make surgery more effective. This randomized clinical trial compared the use of durvalumab alone – already shown to be effective in other cancers – to both the two-drug combination and to using no immunotherapy before mesothelioma surgery. Clinica...
Source: Asbestos and Mesothelioma News - December 19, 2022 Category: Environmental Health Authors: Fran Mannino Tags: Clinical Trials/Research/Emerging Treatments Immunotherapy Pleural Source Type: news

Final Exams Don't Have to Be High Stress for Your Teen
SUNDAY, Dec. 18, 2022 -- Final exams are stressful for students, but it is possible to ratchet down the pressure with some planning and self-compassion. A psychologist from Baylor College of Medicine in Houston offers a few suggestions for helping... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 18, 2022 Category: General Medicine Source Type: news

How Gene Editing Could Help Solve the Problem of Poor Cholesterol
Cardiovascular disease is the leading cause of death in the U.S. and around the world. Though it’s held the top spot for decades, it wasn’t always the king of mortal maladies. Its ascension was propelled by two of medical science’s greatest successes. “Before the 20th century, heart disease was an uncommon cause of death,” says Dr. Michael Shapiro, a professor of cardiology at the Wake Forest University School of Medicine. Bacterial infections such as tuberculosis and dysentery, as well as smallpox and other contagious viruses, were common killers. “Antibiotics and vaccines changed every...
Source: TIME: Health - December 6, 2022 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized healthscienceclimate heart health Source Type: news

All the Flavor, Better Health: Holiday Dinner Ingredient Swaps That Work
WEDNESDAY, Nov. 23, 2022 -- Holiday meals offer an opportunity to indulge in some favorite foods. Now for those who want to enjoy healthier versions of these holiday treats, a registered dietitian from Baylor College of Medicine in Houston offers... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 23, 2022 Category: General Medicine Source Type: news

Vision Is Vulnerable With Age: Here's What to Look For
SUNDAY, Nov. 6, 2022 -- Routine eye checks can help ensure seniors know if they ' re developing any age-related vision issues. An expert from Baylor College of Medicine spells out what seniors need to know. " Don ' t blame vision issues on just aging... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 6, 2022 Category: General Medicine Source Type: news

' Drug factory' implants eliminate mesothelioma tumors in mice
Researchers at Rice University and Baylor College of Medicine have shown they can eradicate advanced-stage mesothelioma tumors in mice in just a few days with a treatment combining Rice ' s cytokine " drug factory " implants and a checkpoint inhibitor … (Source: NSF News)
Source: NSF News - October 19, 2022 Category: Science Authors: NSF Source Type: news

Obesity should be considered a brain disorder like autism or ADHD, US doctors sensationally claim 
Researchers from Baylor College of Medicine in Texas have made the recommendation after a study indicated obesity was caused by changes in the brain during childhood. (Source: the Mail online | Health)
Source: the Mail online | Health - September 29, 2022 Category: Consumer Health News Source Type: news

UAMS Fellow Chosen for Fellowship Backed by NASA (Movers & Shakers)
Ashley Nemec-Bakk is one of three researchers nationwide chosen for the Translational Research Institute for Space Health (TRISH) at Baylor College of Medicine. (Source: Arkansas Business - Health Care)
Source: Arkansas Business - Health Care - September 12, 2022 Category: American Health Source Type: news

Study: ‘ Drug-Factory ’ Technology Kills Mesothelioma Tumor Cells in Mice
Tiny, drug-producing beads implanted in the chest cavity could one day provide a powerful platform that would change the way mesothelioma cancer is treated. In a recent study, researchers from Rice University and the Baylor College of Medicine demonstrated the implants’ impressive effectiveness in mice, raising hopes of a possible breakthrough for this tough-to-treat cancer. Researchers have already met with the U.S. Food and Drug Administration, and hope to open a clinical trial to begin testing the procedure’s effectiveness on mesothelioma patients by the second half of 2023. Clinical Cancer Research publis...
Source: Asbestos and Mesothelioma News - August 30, 2022 Category: Environmental Health Authors: Fran Mannino Tags: Clinical Trials/Research/Emerging Treatments Source Type: news